The Diagnostic Imperative in Oncology: Technical Sensitivity, Clinical Specificity, and Market Evolution of the CA 125 Test Market
The CA 125 Test Market is a segment of the broader diagnostics industry focused on the quantitative measurement of Cancer Antigen 125, a glycoprotein marker primarily used in the management of ovarian cancer. While it is not a screening test for the general population due to its limited specificity (elevated levels can occur in benign conditions like endometriosis or fibroids), it is widely utilized for two critical purposes: monitoring the response to treatment in women diagnosed with ovarian cancer and detecting recurrence following remission. Market growth is closely tied to the increasing global incidence of ovarian cancer, the development of more sensitive and automated immunoassay platforms for measurement, and the increasing volume of cancer survivors requiring long-term surveillance. Key drivers include advancements in laboratory automation, which allow for high-throughput testing, and the…